Paolo De Vidi
About Paolo De Vidi
Paolo De Vidi is a Sales Manager Immuno Oncology with extensive experience in sales and marketing within the oncology sector, currently working at both Sanofi Genzyme and Bristol-Myers Squibb.
Company
Paolo De Vidi is currently working at Sanofi Genzyme as the Sales & Marketing Lead for Skin Cancer, and also serves as the Field Lung Cancer Lead in Milano. He has held multiple positions at Sanofi Genzyme, including Onco-Hematology Innovative Medicines Lead. Previously, he held various roles at Bristol-Myers Squibb, including Sales Manager Immuno-Oncology and Sales Manager BU Onco-Ematology.
Title
Paolo De Vidi holds several key titles, including Sales Manager Immuno-Oncology and Sales Manager BU Onco-Ematology at Bristol-Myers Squibb. He also serves as the Sales & Marketing Lead for Skin Cancer and Field Lung Cancer Lead at Sanofi Genzyme, showcasing his extensive leadership in oncology sales and marketing.
Education and Expertise
Paolo De Vidi studied Farmacia at Università degli Studi di Padova, where he earned a Laurea degree from 1981 to 1985. With this academic background, he has built a robust career specializing in sales and marketing within the oncology sector, particularly in immuno-oncology and onco-hematology.
Professional Background
Paolo De Vidi has a diverse background in the pharmaceutical industry, particularly in oncology. He started his current role at Sanofi Genzyme in March 2021. Prior to that, he served in multiple roles at both Sanofi Genzyme and Bristol-Myers Squibb. His roles have spanned across various fields, including Sales & Marketing Lead for Libtayo in 2020-2021, Onco-Hematology Innovative Medicines Lead, and Area Manager positions for CNS, CV & Metabolic at Bristol-Myers Squibb.
Achievements
Paolo De Vidi has accumulated broad experience in sales and marketing over his extensive career in oncology. His leadership roles at Sanofi Genzyme and Bristol-Myers Squibb have involved significant responsibilities in skin cancer, lung cancer, immuno-oncology, and onco-hematology. His academic background in pharmacy from the Università degli Studi di Padova laid the foundation for his specialized expertise in these areas.